Publicacions
-
Balaguer-Lluna L, Resa-Parés C, Brstilo L, Gómez-Caballero A, Baulenas-Farrés M, Mohr J, Hu Y, Aschero MR, Rodríguez A, Botteri G, Rodriguez E, Li-Chen L, Mañogil R, Marino F, Martinez N, Ruano A, García-Pelayo Á, Giron A, Mora J, Lavarino C, Sánchez-Navarro M, Teixidó M, Ormazabal-Herrero A, Artuch-Iriberri R, Unceta N, Schaiquevich P and Carcaboso AM.
CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas.
CANCER CHEMOTHERAPY AND PHARMACOLOGY . 96(1): .
-
Lomba, L, Polo, A, Martinez N, Alejandre, J and Giner, B.
Solubility and Stability of Carvedilol in Deep Eutectic Solvents: A Step Towards a Sustainable Pharmaceutical Formulation in the Liquid State
ChemistrySelect . 9(11): . Nº de cites: 10
-
Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM.
Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.
BIOCHEMICAL PHARMACOLOGY . 208: 115408-115408. Nº de cites: 10
-
Lomba, L, Polo, A, Alejandre, J, Martinez N and Giner, B.
Solubility enhancement of caffeine and furosemide using deep eutectic solvents formed by choline chloride and xylitol, citric acid, sorbitol or glucose
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY . 79: . Nº de cites: 32
